Survival Advantage of Treosulfan Plus Fludarabine Before Allogeneic Hematopoietic Cell Transplantation for Older or Comorbid Patients With Myeloid Malignancies-Reference-Cited by-同舟云学术

Survival Advantage of Treosulfan Plus Fludarabine Before Allogeneic Hematopoietic Cell Transplantation for Older or Comorbid Patients With Myeloid Malignancies

Published:2021-11 Issue:11 Volume:27 Page:916.e1-916.e6
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Sakellari Ioanna,Gavriilaki Eleni,Mallouri Despina,Batsis Ioannis,Varelas Christos,Tagara Sofia,Bousiou Zoi,Papathanasiou Maria,Vardi Anna,Papalexandri Apostolia,Vadikoliou Chrysanthi,Athanasiadou Anastasia,Lalayanni Chrysavgi,Fylaktou Asimina,Antoniadis Konstantinos,Anagnostopoulos Achilles

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference40 articles.

1. Treosulfan-based conditioning before hematopoietic SCT: more than a BU look-alike;Danylesko;Bone Marrow Transplant,2012

2. Treosulfan-based conditioning regimens for allogeneic haematopoietic stem cell transplantation in children with non-malignant diseases;Slatter;Bone Marrow Transplant,2015

3. Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in children with sickle cell disease;Strocchio;Br J Haematol,2015

4. European Society for Blood and Marrow Transplantation Analysis of Treosulfan Conditioning Before Hematopoietic Stem Cell Transplantation in Children and Adolescents With Hematological Malignancies;Boztug;Pediatr Blood Cancer,2016

5. Myeloablative and immunosuppressive properties of treosulfan in mice;Sjoo;Exp Hematol,2006

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treosulfan- Versus Busulfan-based Conditioning in Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Single-center Retrospective Propensity Score-matched Cohort Study;Transplantation and Cellular Therapy;2024-07

2. Alteration of Gut Microbiota Composition and Diversity in Acute and/or Chronic Graft-versus-Host Disease Following Hematopoietic Stem Cell Transplantation: A Prospective Cohort Study;International Journal of Molecular Sciences;2024-05-26

3. Treosulfan-Based Conditioning Regimen In Pediatric Hematopoietic Stem Cell Transplantation: A Retrospective Analysis on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC);Transplantation and Cellular Therapy;2023-11

4. Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP);Bone Marrow Transplantation;2023-07-07

5. Comparative study of treosulfan plus Fludarabine (FT14) with busulfan plus Fludarabine (FB4) for acute myeloid leukemia in first or second complete remission: An analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP);Bone Marrow Transplantation;2022-09-22